Discover BioRestorative's Upcoming Financial Results Conference
BioRestorative Therapies Announces Financial Results Conference
MELVILLE, N.Y. — BioRestorative Therapies, Inc. (NASDAQ: BRTX), a pioneering company in the field of regenerative medicine, has revealed plans to announce its financial results for the year 2024. This important event is set to occur after the market closes on March 27, 2025. Following the earnings announcement, the management team of BioRestorative will conduct a conference call to discuss the results and provide valuable insights into the company's future direction.
Key Details of the Conference Call
Date and Time: The conference call is scheduled for Thursday, March 27, 2025, at 4:30 p.m. ET. This call represents an excellent opportunity for stakeholders to engage directly with the management team and understand the company's performance and strategic vision.
Dial-In Information: Interested participants can join the call by utilizing the following information:
- Domestic Call-In Number: 1-888-506-0062
- International Call-In Number: 1-973-528-0011
- Access Code: 726526
For those unable to participate directly, the call will also be broadcast live and made available for playback on the company's website under the “Events” section. This ensures that all interested parties can remain informed about the company's activities and achievements.
About BioRestorative Therapies, Inc.
BioRestorative Therapies is dedicated to the innovative development of therapeutic products that utilize cell and tissue protocols, primarily focusing on adult stem cells. The company has centered its clinical efforts on two main programs: treating disc/spine diseases and addressing metabolic disorders. In addition, BioRestorative has ventured into the BioCosmeceutical space, presenting a variety of new products.
Disc/Spine Program
One of BioRestorative's flagship treatments is the brtxDISC™ program, which features BRTX-100. This treatment is derived from the patient's own mesenchymal stem cells harvested from bone marrow, aimed at offering an innovative solution for painful lumbar disc disorders. The therapeutic approach is designed for patients seeking alternatives to invasive surgical procedures. Currently, a Phase 2 clinical trial is investigating BRTX-100's efficacy in treating chronic lower back pain due to degenerative disc disease.
Metabolic Program
In response to the growing obesity crisis, BioRestorative is developing its ThermoStem® program, which entails creating cell-based therapies targeting metabolic disorders. This approach involves utilizing brown adipose-derived stem cells (BADSC) to foster the generation of brown adipose tissue (BAT), aiming to enhance metabolic regulation. Early-stage preclinical studies suggest that increased BAT levels could lead to reduced risks of obesity and diabetes.
BioCosmeceutical Innovations
BioRestorative is also focused on advancing its commercial BioCosmeceutical platform. Their first product introduces a cell-based secretome composed of exosomes, proteins, and growth factors that promise cosmetic benefits, including a reduction in fine lines and wrinkles. The company is committed to broadening its aesthetic product offerings with the goal of achieving FDA approvals in this emerging field.
Investor Contact Information
For investors looking for further information, Stephen Kilmer, the Director of Investor Relations, is available to respond to inquiries. He can be reached at (646) 274-3580, or via email at skilmer@biorestorative.com.
Frequently Asked Questions
When will BioRestorative release its financial results?
BioRestorative will release its 2024 financial results on March 27, 2025, after market close.
What is the purpose of the conference call?
The conference call will provide an overview of the financial results and updates on the company's business strategies and growth trajectory.
What innovative treatments does BioRestorative offer?
BioRestorative specializes in regenerative medicine, focusing on therapies for disc/spine diseases and metabolic disorders using advanced stem cell technologies.
How can investors participate in the conference call?
Investors can join the conference call using the provided domestic or international dial-in numbers and the specified access code.
Where can I find more information about BioRestorative?
More details about BioRestorative Therapies can be found on their official website, where they maintain an investor relations section.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.